VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $112,407,000 | -29.4% | 630,155 | -12.1% | 3.48% | -22.0% |
Q2 2015 | $159,222,000 | -12.6% | 716,730 | -21.9% | 4.47% | -9.2% |
Q1 2015 | $182,186,000 | -7.7% | 917,261 | -33.5% | 4.92% | -10.7% |
Q4 2014 | $197,292,000 | -11.1% | 1,378,606 | -18.5% | 5.51% | -15.6% |
Q3 2014 | $221,928,000 | +13.4% | 1,691,525 | +9.1% | 6.53% | +10.5% |
Q2 2014 | $195,622,000 | -7.1% | 1,551,076 | -2.9% | 5.91% | -12.2% |
Q1 2014 | $210,604,000 | -3.0% | 1,597,540 | -13.6% | 6.73% | -7.5% |
Q4 2013 | $217,096,000 | +1.9% | 1,849,200 | -9.5% | 7.28% | -9.3% |
Q3 2013 | $213,129,000 | +18.2% | 2,042,835 | -2.5% | 8.02% | +9.9% |
Q2 2013 | $180,357,000 | – | 2,095,230 | – | 7.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |